Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer

NCT00003968 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: bryostatin 1

Sponsor

National Cancer Institute (NCI)